Solenn Brosseau

Solenn Brosseau

UNVERIFIED PROFILE

Are you Solenn Brosseau?   Register this Author

Register author
Solenn Brosseau

Solenn Brosseau

Publications by authors named "Solenn Brosseau"

Are you Solenn Brosseau?   Register this Author

28Publications

735Reads

16Profile Views

Trials of Prophylactic Irradiation of Tracts: What is the Appropriate End Point?

J Clin Oncol 2019 Oct 22;37(29):2693. Epub 2019 Aug 22.

Gérard Zalcman, MD, PhD, Hôpital Bichat, Université Paris-Diderot, Paris, France; and Solenn Brosseau, MD and Valérie Gounant, MD, CIC1425 INSERM, Hôpital Bichat-Claude Bernard, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.19.00927DOI Listing
October 2019

Immunotherapy for cancer in people living with HIV: safety with an efficacy signal from the series in real life experience.

AIDS 2019 Sep;33(11):F13-F19

Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, équipe Theravir, AP-HP, Hôpitaux Universitaires Pitié Salpêtrière - Charles Foix, Maladies Infectieuses et Tropicales, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000002298DOI Listing
September 2019

Clinicopathological and Molecular Study of Peritoneal Carcinomatosis Associated with Non-Small Cell Lung Carcinoma.

Pathol Oncol Res 2019 Aug 12. Epub 2019 Aug 12.

Assistance Publique - Hôpitaux de Paris, département de pathologie, Hôpital Bichat-Claude Bernard, Paris, France.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12253-019-00713-1
Publisher Site
http://dx.doi.org/10.1007/s12253-019-00713-1DOI Listing
August 2019

Association of TP53 mutations with response and longer survival under immune checkpoint inhibitors in advanced non-small-cell lung cancer.

Lung Cancer 2019 Jun 8;132:65-71. Epub 2019 Apr 8.

Thoracic Oncology Department, University Hospital Bichat-Claude Bernard, Assistance Publique-Hôpitaux de Paris (AP-HP), 46 rue Henri Huchard, 75018, Paris, France; U830 INSERM "Genetics and biology of cancers", Research Centre, Institut Curie, 26 rue d'Ulm, 75005, Paris, France; Medicine Faculty, University Paris-Diderot, 46 rue Henri Huchard, 75018 Paris, France. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01695002193039
Publisher Site
http://dx.doi.org/10.1016/j.lungcan.2019.04.005DOI Listing
June 2019

Minimal Change Disease Induced by Lorlatinib.

J Thorac Oncol 2018 08;13(8):e154-e156

Service de néphrologie, Hôpital Bichat-Claude Bernard, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.03.033DOI Listing
August 2018

(J)ALEX the great: a new era in the world of ALK inhibitors.

J Thorac Dis 2018 Jul;10(Suppl 18):S2138-S2143

Thoracic Oncology Department, University Hospital Bichat-Claude Bernard, University Paris-Diderot, Paris, France.

View Article

Download full-text PDF

Source
http://jtd.amegroups.com/article/view/22421/17258
Publisher Site
http://dx.doi.org/10.21037/jtd.2018.06.142DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6072949PMC
July 2018

Immunotherapy in relapsed mesothelioma.

Immunotherapy 2018 02;10(2):77-80

Pulmonary & Thoracic Oncology, Univ Lille, CHU Lille, INSERM U1019, CIIL, Institut Pasteur de Lille, F59000 Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt-2017-0144DOI Listing
February 2018

Lazarus Syndrome With Crizotinib in a Non-Small Cell Lung Cancer Patient With ROS1 Rearrangement and Disseminated Intravascular Coagulation.

Clin Lung Cancer 2018 01 3;19(1):e57-e61. Epub 2017 Aug 3.

Service d'Oncologie Thoracique, CIC-1425/CLIP(2) Paris-Nord, Université Paris-Diderot, Hôpital Bichat-Claude Bernard, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2017.07.003DOI Listing
January 2018

Bevacizumab in advanced lung cancer: state of the art.

Future Oncol 2017 Dec 16;13(28):2515-2535. Epub 2017 Aug 16.

Department of Thoracic Oncology & CIC 1425/CLIP2 Paris-Nord, Bichat-Claude Bernard Hospital, APHP, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2017-0302DOI Listing
December 2017

A review of bevacizumab in the treatment of malignant pleural mesothelioma.

Future Oncol 2017 Dec 20;13(28):2537-2546. Epub 2017 Sep 20.

Department of Thoracic Oncology & CIC 1425/CLIP2 Paris-Nord, Bichat-Claude Bernard Hospital, APHP, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2017-0307DOI Listing
December 2017

[Therapeutic advances in lung cancer].

Rev Prat 2017 01;67(1):47-50

Service d'oncologie thoracique, CIC1425/ CLIP2 Paris-Nord, université Paris- Diderot, hôpital Bichat-Claude-Bernard, AP-HP, Paris, France.

View Article

Download full-text PDF

Source
January 2017

Pre-Emptive or Reactive Treatment of Cutaneous Rash Induced by Epidermal Growth Factor Receptor Inhibitors: Does It Matter?

J Clin Oncol 2016 Mar 28;34(8):774-6. Epub 2015 Dec 28.

Bichat-Claude Bernard University Hospital, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.64.7529DOI Listing
March 2016

[Malignant pleural mesothelioma: rare and aggressive but with new therapeutic perspectives].

Rev Prat 2016 Feb;66(2):191-197

Service d'oncologie thoracique, hôpital Bichat- Claude Bernard, université Paris-Diderot, Paris, France.

View Article

Download full-text PDF

Source
February 2016

[3rd generation's TKI in lung cancer non-small cell EGFR-mutated having acquired a secondary T790M resistance].

Bull Cancer 2015 Sep 30;102(9):749-57. Epub 2015 Jul 30.

Institut Gustave-Roussy, département d'innovation thérapeutique et d'essais précoces, 94800 Villejuif, France; Institut Gustave-Roussy, département de médecine oncologique, 94800 Villejuif, France; Université Paris-Sud, 91400 Orsay, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2015.05.001DOI Listing
September 2015

[Resistances to targeted therapies and strategy for following therapeutic lines in metastatic NSCLC].

Bull Cancer 2015 Jun;102(6 Suppl 1):S27-33

Service de pneumologie et oncologie thoracique, Université de Caen-Basse Normandie, Hôpital de la Côte-de-Nacre, 14033 Caen CS 3001, France; UMR Inserm 1086 Cancers et préventions, Université de Caen-Basse Normandie, Hôpital de la Côte-de-Nacre, 14033 Caen CS 3001, France; Centre de recherche clinique/Essais de phases précoces, Université de Caen-Basse Normandie, Hôpital de la Côte-de-Nacre, 14033 Caen CS 3001, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0007-4551(15)31215-7DOI Listing
June 2015

[Second generation ALK inhibitors in non-small cell lung cancer: systemic review].

Bull Cancer 2015 Apr 25;102(4):381-9. Epub 2015 Mar 25.

Institut Gustave-Roussy, département d'innovation thérapeutique et d'essais précoces, 94805 Villejuif, France; Institut Gustave-Roussy, département de médecine oncologique, 94805 Villejuif, France; Université Paris-Sud, 75011 Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2015.02.016DOI Listing
April 2015

[Malignant pleural mesothelioma: 2013 state of the art].

Bull Cancer 2013 Dec;100(12):1283-93

Université de Caen-Basse Normandie, CHU de Caen, service de pneumologie et oncologie thoracique, avenue de la Côte-de-Nacre, 14033 Caen cedex 05, France, CHU de Caen, UMR Inserm 1086 « Cancers et Préventions », avenue Côte-de-Nacre, 14033 Caen Cedex 05 France, Intergroupe francophone de cancérologie thoracique (IFCT), 10, rue de la Grange-Batelière, 75009 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1684/bdc.2013.1857DOI Listing
December 2013